Lexicon Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript
It is my pleasure to introduce Lonnel Coats, President and Chief Executive Officer at Lexicon Pharmaceuticals, to present at the Jefferies Virtual Healthcare Conference.
Thank you and thank you all for joining us on this conference. I'm Lonnel Coats, President and Chief Executive Officer of Lexicon Pharmaceuticals. Today I'll be making this presentation on behalf of all the extraordinary men and women here at Lexicon who toils every day to advance our science into the hands of patients. Also today I will be making forward-looking statements, some of these will have risks. All of my risks are covered in our SEC filings.
Let me jump right in. For those who may not be familiar with Lexicon, we have a scientific platform that has produced two approved products in a pipeline of innovative drug candidates. The first approved product is XERMELO, which is proved here in the United States for carcinoid syndrome diarrhea, and we have a partnership outside the US in Japan with Ipsen
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
